Residual Cardiovascular Risk Determined through Posthoc Analysis of the REAL-CAD Trial
Journal of Atherosclerosis and Thrombosis · 2024
DOI: 10.5551/jat.ed245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2024. Verfasst von Yasuhiro Endo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Coronary Artery Disease, Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College.
- Division of Environmental Medicine, National Defense Medical College Research Institute.
Zitieren
APA
Endo, Y., Sasaki, K., & Ikewaki, K. (2024). Residual Cardiovascular Risk Determined through Posthoc Analysis of the REAL-CAD Trial. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.ed245
Vancouver
Endo Y, Sasaki K, Ikewaki K. Residual Cardiovascular Risk Determined through Posthoc Analysis of the REAL-CAD Trial. Journal of Atherosclerosis and Thrombosis. 2024. doi:10.5551/jat.ed245
BibTeX
@article{Endo2024,
author = {Endo, Yasuhiro and Sasaki, Kei and Ikewaki, Katsunori},
title = {Residual Cardiovascular Risk Determined through Posthoc Analysis of the REAL-CAD Trial},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2024},
doi = {10.5551/jat.ed245}
}
EUVIMED